Investors
Icade Santé is now Praemia Healthcare
Following the July 5, 2023 announcement with respect to Primonial REIM France's acquisition of 63% of the shares owned by Icade in Icade Santé for €1.4 billion, the real estate investment company Icade Santé became Praemia Healthcare.
Fraud warning
Remain Vigilant
Praemia Healthcare alerts you to the existence of fake canvassers pretending to be Praemia Healthcare representatives.
Regulatory information archive
Regulatory information
Document
![]()
Praemia Healthcare - Half Year 2024 Results
Document
![]()
CP - Praemia Healthcare - 2023 Annual Report Release
Document
![]()
Praemia Healthcare completes its 2024 refinancing plan by signing four unsecured bilateral sustainability-linked credit lines for €160m
Document
![]()
Praemia Healthcare - 2023 Full Year Results
Document
![]()
Successful launch of Praemia Healthcare’s inaugural sustainable bond issue
Document
![]()
Successful launch of Praemia Healthcare’s inaugural sustainable bond issue
Document
![]()
Icade Santé- Résultats 2022 - Rapport Audit Comptes Annuels (FR only)
Document
![]()
Icade Santé - Résultats 2021 - Rapport Audit Comptes Annuels (FR only)
Document
![]()
Statutory Auditors’ review report on the condensed half-year consolidated financial statements - Jan to June 2023
Document
![]()
Half Year 2023 Results
Document
![]()
Icade and Primonial REIM sign an exclusivity agreement for the acquisition of Icade's stake in Icade Santé
Document
![]()
Icade Santé - 2022 Full Year Results
Document
![]()
Half Year 2022 Results
Document
![]()
Icade Santé adds to its portfolio in Spain and completes the sale of four healthcare facilities in France
Document
![]()
New appointment at Icade Santé: Laurent Poinsard named General Secretary
Document
![]()
Opportunistic sale of four healthcare facilities in France for €78m & Ongoing optimisation of the balance sheet
Document
![]()
Icade Santé - 2021 Full Year Results
Document
![]()
Icade Santé invests again in Spain by acquiring an eye clinic in Madrid for €13M
Document
![]()
Icade Santé acquires a portfolio of four private hospital properties in Portugal for €213M
Document
![]()
Icade Santé continues to expand into Germany with ORPEA
Load next
Long-term capital market financing (for operations in France)
| LONG-TERM RATING | BBB |
| SHORT-TERM RATING | A2 |
| PERSPECTIVE | Stable |
| SINCE | July 2024 |
Praemia Healthcare diversifies by issuing euro-denominated bonds.
General Meeting of Bondholders
Publications & Financial Reports
Document
![]()
Condensed Consolidated Financial Statements as of June 30, 2024
Document
![]()
Praemia Healthcare - 2023 Annual report
Document
![]()
Condensed Consolidated Financial Statements as of December 31, 2023
Document
![]()
Praemia HEALTHCARE Final Prospectus
Document
![]()
Condensed consolidated financial statements as of June 30, 2023
Document
![]()
Condensed consolidated financial statements as of June 30, 2023
Document
![]()
Icade Santé - 2022 Consolidated Financial Statements
Document
![]()
Combined Financial Statements H1 2022 - Healthcare Property Investment Division
Document
![]()
Icade Santé - Condensed consolidated financial statements as of June 30, 2022
Document
![]()
Icade Santé - 2021 Consolidated Financial Statements
Document
![]()
Icade Santé’s first annual Social Bond report (2021)
Document
![]()
Condensed consolidated financial statements as of June 30, 2021
Document
![]()
Consolidated financial statements 2020
Document
![]()
Investor Presentation - Icade Santé Social Bond
Document
![]()
Icade Santé - Social Bond Final Prospectus
Document
![]()
Icade Santé Social Bond Framework Second-Party Opinion
Document
![]()
Icade Santé’s Social Bond framework (September 2020)
Document
![]()
Investor Presentation - Icade Santé - Deal Roadshow (october 2019)
Document
![]()
Icade Santé - Final Prospectus
Document
![]()
Icade Santé - consolidated financial statements as of december 31, 2018, 2017 and 2016
Document
![]()
Condensed consolidated financial statements as of June 30,2019
Load next
et Firefox 
